Bristol Myers Squibb (BMS) is bringing a $2.3 billion drug manufacturing campus and 500 jobs to Houston.
The New Jersey-based pharmaceutical manufacturer said in an Aug. 10 announcement that it had selected the city for the 600,000-square-foot campus, which will be built to speed up the delivery of what it calls “next-generation medicines to patients.”
“This investment reflects our confidence in America’s continued leadership in biopharmaceutical innovation,” Christopher Boerner, board chair and CEO of BMS, said. “As part of our $40 billion commitment to the United States, we’re building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life.”…